PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 4, 2011Circulation1,769 citationsOpen Access

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

View Full Paper
SSSidney C. SmithEBEmelia J. BenjaminRBRobert O. Bonow

Key Points

  • To provide updated, evidence-based recommendations for secondary prevention and risk reduction therapies in patients diagnosed with coronary and other atherosclerotic vascular diseases.
  • Expert consensus panel and comprehensive literature review conducted by the AHA and ACCF task force.

Structured PICO

P
Population
Patients with coronary and other atherosclerotic vascular disease
I
Intervention
Secondary prevention and risk reduction therapy

This document provides the 2011 update to the AHA/ACCF guidelines for secondary prevention and risk reduction therapy in patients with coronary and other atherosclerotic vascular disease.

Abstract

The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Smith et al. (2011) studied this question.

synapsesocial.com/papers/69a725078724a1de474f14achttps://doi.org/10.1161/cir.0b013e318235eb4d
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults2013 · 219 citations
  2. 2AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update2002 · 1,863 citations
  3. 32019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary2019 · 1,196 citations
  4. 4The Secondary Prevention of Coronary Artery Disease1997 · 47 citations
  5. 5Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines2014 · 47 citations